Compare PRPO & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | YSXT |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Automotive Aftermarket |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.3M | 41.4M |
| IPO Year | 2000 | 2023 |
| Metric | PRPO | YSXT |
|---|---|---|
| Price | $19.02 | $1.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 34.2K | 6.5K |
| Earning Date | 11-10-2026 | 07-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.15 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,049,000.00 | N/A |
| Revenue This Year | $233.72 | N/A |
| Revenue Next Year | $22.61 | N/A |
| P/E Ratio | ★ N/A | $5.57 |
| Revenue Growth | ★ 29.77 | N/A |
| 52 Week Low | $17.79 | $0.50 |
| 52 Week High | $33.63 | $3.14 |
| Indicator | PRPO | YSXT |
|---|---|---|
| Relative Strength Index (RSI) | 39.94 | 48.90 |
| Support Level | $19.37 | $1.21 |
| Resistance Level | $24.78 | $1.51 |
| Average True Range (ATR) | 1.01 | 0.08 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 37.67 | 54.05 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services, and Software Development and Information Technology Services. Key revenue is generated from the Auto Insurance Aftermarket Value-added Services segment, which includes four types of value-added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services, and vehicle maintenance and other value-added services.